National Graphite Corp. (NGRC)の価格はいくらですか

National Graphite Corp. (NGRC)の価格は$0.021です

National Graphite Corp. (NGRC)の時価総額は何ですか

National Graphite Corp. (NGRC)の時価総額は$3.24Mです

National Graphite Corp.（NGRC）営業利益率

National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.

年	営業利益率	変化
提供された日付のデータは十分ではありません。

年

営業利益率

変化

提供された日付のデータは十分ではありません。

企業	営業利益率	営業利益率の差	国
Clone Algo Technologies Inc. CATI.US	0.00%	-	US
Worldwide Webb Acquisition Corp. WWAC.US	0.00%	-	US
Gushen, Inc. GSHN.US	0.00%	-	CN
Apollo Strategic Growth Capital APSG.US	0.00%	-	US
Digital World Acquisition Corp. DWAC.US	0.00%	-	US

企業

営業利益率

営業利益率の差

国